Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which anesthesia gets you home faster after joint replacement?

NCT ID NCT07334132

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares general anesthesia (being fully asleep) with spinal anesthesia (numbing the lower body) in 600 adults having knee or hip replacement as outpatient surgery. The goal is to see which method leads to successful same-day discharge without readmission. Researchers will also track pain, nausea, recovery time, and patient satisfaction up to 12 months after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
general anesthesia (propofol and remifentanil) or spinal anesthesia
What this could lead to
If successful, this could show which anesthesia method helps patients go home sooner and recover more comfortably after joint replacement surgery.
What could go wrong
This is a phase 4 trial comparing two standard techniques, so no breakthrough is expected. Results may not apply to all patients or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The participant has given their written consent to participate in the trial. 2. Planned for primary TKA or THA. 3. Adults aged 18 to 80 years at time of written consent. 4. ASA (American Society of Anaesthesiologists) classification 1 or 2, or 3 without significant functional impairment. 5. Scheduled start of surgery before 13:00. 6. Ability to communicate in Swedish, ensuring understanding of informed consent and follow-up procedures. Exclusion Criteria: 1. Indication for surgery other than degenerative or inflammatory joint diseases (e.g. fracture). 2. Body mass index (BMI) \> 35 kg/m. 3. Preoperative opioid use exceeding 20 mg oral morphine equivalents daily. 4. Haemoglobin \< 120 g/L (sample no older than 3 months). 5. Known bleeding disorders, including coagulopathies. 6. Known allergies to investigational anaesthetic drugs (e.g., bupivacaine, remifentanil, or propofol). 7. Neurological conditions with persistent motor or sensory deficits. 8. Localised infections at the spinal injection site. 9. Determined by the surgical or anaesthesia team to be unsuitable for trial participation and/or outpatient surgery. 10. Women of childbearing potential (i.e., those who are fertile, following menarche and until becoming post-menopausal, unless permanently sterile) 1. Who are not willing to use a highly effective method of contraception judged by the investigator, from the time of signing the informed consent, OR 2. Who has a positive pregnancy test at enrolment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inflammatory joint disease (IJD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.